Does Teva Pharmaceutical Industries Ltd (ADR) (TEVA)’s Dividend Have Room to Soar?

Valuation
Not all dividends are created equal. At first glance a high dividend yield may look nice, but all too often it means a problem is lurking around the corner for a business. Looking at Teva’s 3% dividend yield in isolation only tells half of the story, which is why investors need to have an understanding of how the market perceives a company prior to buying a stock. We can do this by comparing a few financial multiples, like price to earnings, to its peers in the industry.

Future growth
Up to this point, we’ve looked at Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA)’s dividend in the past, and we’ve also seen how its stock is being perceived by the market today. However, the most important factor to consider when understanding a dividend’s future is where the company’s cash flow is heading. It’s hard to generate more cash without growing sales, so let’s take a look at what industry analysts are expecting for Teva’s revenue growth relative to peers this year.

Foolish bottom line

Does Teva Pharmaceutical Industries Ltd (ADR) (TEVA)’s Dividend Have Room to Soar?

Published on March 14, 2013 at 4:40 pm by The Motley Fool in News

AI Fire Sale: Insider Monkey’s #1 AI Stock Pick Is On A Steep Discount

Published on April 11, 2024 at by Inan Dogan, PhD

50-year Wall Street Insider Names #1 stock for AI “Tidal Wave”

Published on April 1, 2024 at by Insider Monkey Staff